caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1841227428

NPI 1841227428

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where NPI 1841227428's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 52 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
92198
MAIN LINE HOSPITALS, INC.4971
EINSTEIN MEDICAL CENTER MONTGOMERY4368
225 EVERGREEN ROAD OPERATIONS LLC4048
TRAPPE FIRE COMPANY NO 13333
Meng-Chao Lee
Geriatric Medicine · Philadelphia, PA
3348
Raffi Megerian
Internal Medicine · Audubon, PA
3156
Steven Greenberg
Diagnostic Radiology · Phoenixville, PA
3037
MERCY SUBURBAN HOSPITAL2850
CHHS HOSPITAL COMPANY LLC2435
Mimi Pinto
Diagnostic Radiology · Philadelphia, PA
2325
WHITEMARSH CONTINUING CARE RETIREMENT COMMUNITY2226
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.